United Kingdom · Question · Written question
UIN 35772
Myasthenia Gravis: Health Services
Introduced
5 March 2025
Last action
12 March 2025 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
12 March 2025
Summary
To ask the Secretary of State for Health and Social Care, what discussions he has had with (a) NHS England, (b) the Medicines and Healthcare products Regulatory Agency and (c) the National Institute for Health and Care Excellence on the availability of (i
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
5 March 2025
Written question
To ask the Secretary of State for Health and Social Care, what discussions he has had with (a) NHS England, (b) the Medicines and Healthcare products Regulatory Agency and (c) the National Institute for Health and Care Excellence on the availability of (i
Source: Commons
12 March 2025
Answer
Working under the UK Rare Diseases Framework, the Government is committed to improving the lives of those living with rare diseases, such as myasthenia gravis. My Rt Hon. Friend, the Secretary of State for Health and Social Care has not specifically discu...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2025-03-05/35772
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1781520
- uk · wq-1781520 · source updated 12 March 2025